Mutual Of America Capital Management LLC Bluebird Bio, Inc. Transaction History

Mutual Of America Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 09, 2018	SELL	$99.64 - $127.59 $4.17 Million - $5.34 Million	-41,870 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$105.8 - $150.94 $9,098 - $12,980	-86 Reduced 0.2%	41,870 $7.15 Million
Q4 2017 Jan 31, 2018	BUY	$81.25 - $130.7 $2.66 Million - $4.28 Million	32,756 Added 356.04%	41,956 $7.47 Million
Q3 2017 Oct 18, 2017	BUY	$57.74 - $91.42 $531,208 - $841,064	9,200	9,200 $1.26 Million

42.6M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $466M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.